Impacto orçamentário da introdução de um sistema de monitoramento flash na avaliação da glicemia em indivíduos com diabetes mellitus tipo 1 na perspectiva do Sistema Único de Saúde.

Saved in:

Bibliographic Details
Title:	Impacto orçamentário da introdução de um sistema de monitoramento flash na avaliação da glicemia em indivíduos com diabetes mellitus tipo 1 na perspectiva do Sistema Único de Saúde.
Alternate Title:	Budget impact analysis of a flash monitoring system for glucose control in patients with type 1 diabetes mellitus in the perspective of the public health system in Brazil.
Authors:	da Silva Machado, Fernanda Lacerda¹ fernandalsmachado@macae.ufrj.br
Source:	JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde. dez2024, Vol. 16 Issue 3, p138-144. 7p.
Subjects:	TYPE 1 diabetes, BUSINESS negotiation, BUDGET, PEOPLE with diabetes, TIME perspective, DIRECT costing
Abstract (English):	Objective: This study aims to investigate the budget impact with the introduction of a flash glucose monitoring system for glucose measurement in people with diabetes mellitus type 1 in the perspective of the public health system (SUS, in Portuguese). Methods: The model was built to investigate the differences in costs comparing the current scenario (monitoring with glucometer and tests strips) to the new scenario including the adoption of a flash glucose monitoring system for diabetic patients with greater risk of presenting hypoglycemic events in a time horizon of five years. For costs calculations, it was considered the expenses with the acquisition of technologies, hospitalizations by hypoglycemia and ketoacidosis. Data for the clinical effects were obtained from observational studies and clinical trials published in the literature. Results: The budget impact analysis for the introduction of a flash glucose monitoring system for people with diabetes mellitus type 1 in the perspective of SUS estimated an average incremental cost of R$ 651,87/ patient/year. In five years, the adoption of a flash glucose monitoring system will have an incremental budget impact of approximately R$ 4,8 billion, representing an increase of 73.7% in the expenses with diabetes mellitus type 1 in the fifth year after the incorporation. The sensitivity analysis indicated that the model was more sensitive to variations in the cost of the flash glucose monitoring system and in the eligible population. Conclusions: The incorporation of the technology will have an import impact on the expenses for the monitoring of glycemia in this population. Therefore, the implementation will depend on the definition of restrictive criteria to access the device and/or price negotiation between the Brazilian Ministry of Health and the manufacturers/suppliers of the technology. [ABSTRACT FROM AUTHOR]
Abstract (Portuguese):	Objetivo: Avaliar o impacto orçamentário da introdução de um sistema de monitoramento flash para medição da glicemia em indivíduos com diabetes mellitus tipo 1 na perspectiva do Sistema Único de Saúde. Métodos: Um modelo foi desenvolvido para investigar as diferenças de custos entre o cenário de referência (monitoramento com glicosímetro e fitas) e o novo cenário com a adoção do sistema de monitoramento flash para os indivíduos com diabetes mellitus tipo 1 com maior risco de apresentar episódios de hipoglicemia num horizonte temporal de cinco anos. No cálculo dos custos, consideraram-se os gastos com a aquisição das tecnologias, internações por hipoglicemia e cetoacidose. Dados dos efeitos clínicos foram obtidos de estudos observacionais e clínicos disponíveis na literatura. Resultados: A análise de impacto orçamentário da introdução do sistema de monitoramento flash para indivíduos com diabetes tipo 1 na perspectiva do Sistema Único de Saúde estimou um custo incremental médio de R$ 651,87/paciente/ano. A previsão é que a introdução do novo sistema resulte em um impacto orçamentário incremental de aproximadamente R$ 4,8 bilhões ao longo dos cinco anos, com aumento de 73,7% nos gastos com diabetes mellitus tipo 1 no quinto ano após a incorporação. A análise de sensibilidade indicou que o modelo foi mais sensível às variações de custo do sistema de monitoramento flash e da população elegível. Conclusões: A introdução da tecnologia terá impacto importante nas despesas para o monitoramento da glicemia nessa população, de forma que a implementação dependerá da definição de critérios restritivos de acesso e/ou de negociações de preços entre o Ministério da Saúde e os fabricantes/fornecedores da tecnologia. [ABSTRACT FROM AUTHOR]
	Copyright of JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde is the property of JBES: Brazilian Journal of Health Economics and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	Objective: This study aims to investigate the budget impact with the introduction of a flash glucose monitoring system for glucose measurement in people with diabetes mellitus type 1 in the perspective of the public health system (SUS, in Portuguese). Methods: The model was built to investigate the differences in costs comparing the current scenario (monitoring with glucometer and tests strips) to the new scenario including the adoption of a flash glucose monitoring system for diabetic patients with greater risk of presenting hypoglycemic events in a time horizon of five years. For costs calculations, it was considered the expenses with the acquisition of technologies, hospitalizations by hypoglycemia and ketoacidosis. Data for the clinical effects were obtained from observational studies and clinical trials published in the literature. Results: The budget impact analysis for the introduction of a flash glucose monitoring system for people with diabetes mellitus type 1 in the perspective of SUS estimated an average incremental cost of R$ 651,87/ patient/year. In five years, the adoption of a flash glucose monitoring system will have an incremental budget impact of approximately R$ 4,8 billion, representing an increase of 73.7% in the expenses with diabetes mellitus type 1 in the fifth year after the incorporation. The sensitivity analysis indicated that the model was more sensitive to variations in the cost of the flash glucose monitoring system and in the eligible population. Conclusions: The incorporation of the technology will have an import impact on the expenses for the monitoring of glycemia in this population. Therefore, the implementation will depend on the definition of restrictive criteria to access the device and/or price negotiation between the Brazilian Ministry of Health and the manufacturers/suppliers of the technology. [ABSTRACT FROM AUTHOR]
ISSN:	21752095
DOI:	10.21115/JBES.v16.n3.p138-44